Movement Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Movement Disorders stocks.

Recent Signals

Date Stock Signal Type
2021-05-14 ATHE Bullish Engulfing Bullish
2021-05-14 ATHE Stochastic Buy Signal Bullish
2021-05-14 JAZZ NR7 Range Contraction
2021-05-14 JAZZ Narrow Range Bar Range Contraction
2021-05-14 JAZZ New 52 Week Closing High Bullish
2021-05-14 MDT NR7 Range Contraction
2021-05-14 NAVB Lower Bollinger Band Walk Weakness
2021-05-14 NAVB Bollinger Band Squeeze Range Contraction
2021-05-14 NBIX MACD Bullish Signal Line Cross Bullish
2021-05-14 NBIX Crossed Above 50 DMA Bullish
2021-05-14 NBIX Crossed Above 20 DMA Bullish
2021-05-14 OMER 50 DMA Resistance Bearish
2021-05-14 OMER 20 DMA Support Bullish
2021-05-14 OMER Bollinger Band Squeeze Range Contraction
2021-05-14 OMER Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 OSMT NR7 Range Contraction
2021-05-14 OSMT 20 DMA Support Bullish
2021-05-14 SEEL Crossed Above 50 DMA Bullish

Recent News for Movement Disorders Stocks

Date Stock Title
May 16 MDT Wall Street Breakfast: The Week Ahead
May 14 MDT How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
May 14 MDT New Survey Identifies Opportunity to Improve Shared Decision Making Between Cardiologists and Heart Valve Disease Patients
May 14 MDT The Zacks Analyst Blog Highlights: Mastercard, Home Depot, Disney, Netflix and Medtronic
May 14 JAZZ Avadel to 'vigorously' defend against patent violations claims filed by Jazz
May 14 JAZZ Jazz Pharmaceuticals Has a Good Gig Going
May 14 OSMT How Much Did Osmotica Pharmaceuticals'(NASDAQ:OSMT) Shareholders Earn From Share Price Movements Over The Last Year?
May 14 OSMT Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q1 2021 Results - Earnings Call Transcript
May 13 OSMT Osmotica Pharmaceuticals EPS beats by $0.08, misses on revenue
May 13 OSMT Osmotica Pharmaceuticals plc Reports First Quarter 2021 Results and Provides Business Update
May 13 OSMT Osmotica Pharmaceuticals Plc to Host Earnings Call
May 13 MDT Medtronic to Announce Financial Results for its Fourth Quarter and Full Fiscal Year 2021
May 13 MDT Medtronic and Medtronic Foundation Partner to Address COVID-19 Surges with Focus on Equity
May 13 OMER Omeros’ Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentation at the European Hematology Association Congress
May 13 OSMT Earnings Scheduled For May 13, 2021
May 13 JAZZ Jazz Pharmaceuticals: Undervalued Even Before GW Acquisition Kicks In
May 12 OSMT Osmotica Pharmaceuticals plc to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference
May 12 MDT MedTech Round Up: Update On Lucira Health, Second Sight Medical ClearPoint Neuro, Medtronic, Sientra
May 12 NAVB Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q1 2021 Results - Earnings Call Transcript
May 11 NAVB Navidea Q1 loss widens as revenue drops, R&D expenses rise
Related Industries: Biotechnology Medical Devices

Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, unrelated to weakness or spasticity. Movement disorders are synonymous with basal ganglia or extrapyramidal diseases. Movement disorders are conventionally divided into two major categories- hyperkinetic and hypokinetic.
Hyperkinetic movement disorders refer to dyskinesia, or excessive, often repetitive, involuntary movements that intrude upon the normal flow of motor activity.
Hypokinetic movement disorders refer to akinesia (lack of movement), hypokinesia (reduced amplitude of movements), bradykinesia (slow movement) and rigidity. In primary movement disorders, the abnormal movement is the primary manifestation of the disorder. In secondary movement disorders, the abnormal movement is a manifestation of another systemic or neurological disorder.

More about Movement Disorders
Browse All Tags